These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30110619)

  • 1. Carcinoembryonic antigen-targeted nanoparticles potentiate the delivery of anticancer drugs to colorectal cancer cells.
    Pereira I; Sousa F; Kennedy P; Sarmento B
    Int J Pharm; 2018 Oct; 549(1-2):397-403. PubMed ID: 30110619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: Formulation development and in vitro anticancer activity.
    Pulkkinen M; Pikkarainen J; Wirth T; Tarvainen T; Haapa-aho V; Korhonen H; Seppälä J; Järvinen K
    Eur J Pharm Biopharm; 2008 Sep; 70(1):66-74. PubMed ID: 18555675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro &in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction.
    Xiong XY; Guo L; Gong YC; Li ZL; Li YP; Liu ZY; Zhou M
    Eur J Pharm Sci; 2012 Aug; 46(5):537-44. PubMed ID: 22538053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pegylated polyelectrolyte nanoparticles containing paclitaxel as a promising candidate for drug carriers for passive targeting.
    Szczepanowicz K; Bzowska M; Kruk T; Karabasz A; Bereta J; Warszynski P
    Colloids Surf B Biointerfaces; 2016 Jul; 143():463-471. PubMed ID: 27037784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
    Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
    Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendrimer-stabilized smart-nanoparticle (DSSN) platform for targeted delivery of hydrophobic antitumor therapeutics.
    Tekade RK; Tekade M; Kumar M; Chauhan AS
    Pharm Res; 2015 Mar; 32(3):910-28. PubMed ID: 25205461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.
    Han J; Michel AR; Lee HS; Kalscheuer S; Wohl A; Hoye TR; McCormick AV; Panyam J; Macosko CW
    Mol Pharm; 2015 Dec; 12(12):4329-35. PubMed ID: 26505116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active and passive tumor targeting of a novel poorly soluble cyclin dependent kinase inhibitor, JNJ-7706621.
    Danhier F; Ucakar B; Magotteaux N; Brewster ME; Préat V
    Int J Pharm; 2010 Jun; 392(1-2):20-8. PubMed ID: 20226846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer.
    He Z; Shi Z; Sun W; Ma J; Xia J; Zhang X; Chen W; Huang J
    Tumour Biol; 2016 Jun; 37(6):7809-21. PubMed ID: 26695149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and in-vitro bioactivity evaluation of paclitaxel-loaded polyester nanoparticles.
    López-Gasco P; Iglesias I; Benedí J; Lozano R; Blanco MD
    Anticancer Drugs; 2012 Oct; 23(9):947-58. PubMed ID: 22713593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
    Lv W; Cheng L; Li B
    Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
    Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A targeting drug delivery system for ovarian carcinoma: transferrin modified lipid coated paclitaxel-loaded nanoparticles.
    Li R; Zhang Q; Wang XY; Chen XG; He YX; Yang WY; Yang X
    Drug Res (Stuttg); 2014 Oct; 64(10):541-7. PubMed ID: 24443309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.
    Taghavi S; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Cancer Lett; 2017 Aug; 400():1-8. PubMed ID: 28412238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel.
    Muntimadugu E; Kumar R; Saladi S; Rafeeqi TA; Khan W
    Colloids Surf B Biointerfaces; 2016 Jul; 143():532-546. PubMed ID: 27045981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel controlled delivery using a pH-responsive functional-AuNP/block-copolymer vesicular nanocarrier composite system.
    Liaskoni A; Angelopoulou A; Voulgari E; Popescu MT; Tsitsilianis C; Avgoustakis K
    Eur J Pharm Sci; 2018 May; 117():177-186. PubMed ID: 29477643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan.
    Emami J; Maghzi P; Hasanzadeh F; Sadeghi H; Mirian M; Rostami M
    Pharm Dev Technol; 2018 Jan; 23(1):41-54. PubMed ID: 28608760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: improved drug solubilization and enhanced in vitro cytotoxicity.
    Sawant RR; Sawant RM; Torchilin VP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):51-7. PubMed ID: 18583114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.